{{Rsnum
|rsid=2001350
|Gene=NFE2L2
|Chromosome=2
|position=177235697
|Orientation=minus
|GMAF=0.1451
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 82.3 | 17.7 | 0.0
| HCB | 53.3 | 37.2 | 9.5
| JPT | 61.9 | 31.9 | 6.2
| YRI | 76.7 | 21.9 | 1.4
| ASW | 80.7 | 17.5 | 1.8
| CHB | 53.3 | 37.2 | 9.5
| CHD | 56.9 | 40.4 | 2.8
| GIH | 79.2 | 18.8 | 2.0
| LWK | 76.4 | 23.6 | 0.0
| MEX | 72.4 | 25.9 | 1.7
| MKK | 66.7 | 30.1 | 3.2
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21774808
|Title=An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study
|OA=1
}}

{{PMID Auto
|PMID=20196834
|Title=Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}